Identification of Risk Allels for Prostate Cancer

This study has been completed.
Sponsor:
Information provided by:
University of New Mexico
ClinicalTrials.gov Identifier:
NCT00323388
First received: May 5, 2006
Last updated: January 6, 2010
Last verified: November 2009
  Purpose

Identification of Risk Allels for Prostate Cancer


Condition
Prostate Cancer

Study Type: Observational
Official Title: Identification of Risk Allels for Prostate Cancer

Resource links provided by NLM:


Further study details as provided by University of New Mexico:

Study Start Date: November 2005
Study Completion Date: September 2007
Primary Completion Date: September 2007 (Final data collection date for primary outcome measure)
Detailed Description:

As above.

  Eligibility

Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients with prostate cancer

Criteria

Inclusion Criteria:

  • Patients with prostate cancer.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00323388

Locations
United States, New Mexico
University of New Mexico
Albuquerque, New Mexico, United States, 87131
Sponsors and Collaborators
University of New Mexico
Investigators
Principal Investigator: John Scariano University of New Mexico
  More Information

No publications provided

Responsible Party: John Scariano; Principal Investigator, Universtiy of New Mexico
ClinicalTrials.gov Identifier: NCT00323388     History of Changes
Other Study ID Numbers: HRRC 04-458
Study First Received: May 5, 2006
Last Updated: January 6, 2010
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Prostatic Neoplasms
Genital Neoplasms, Male
Urogenital Neoplasms
Neoplasms by Site
Neoplasms
Genital Diseases, Male
Prostatic Diseases

ClinicalTrials.gov processed this record on September 18, 2014